Company Overview and News
Jacques Gounon, Chairman and Chief Executive Officer of Groupe Eurotunnel SE (Paris:GET) , stated: “Over the past 10 years, the Group has focused its business model on value creation through the quality of service provided. The success of the partial refinancing of the debt shows the confidence of the markets in the strength of this model. The economic outlook for the next two years remains good and enables us to confirm our objectives.
Eurotunnel (Paris:GET) today held an Exclusive Press Preview of its new Flexiplus lounge at the Coquelles terminal in France, as part of the celebrations for the millionth customer to use the Flexiplus service since its introduction in 2006.
Pursuant to the liquidity agreement entered into by Groupe Eurotunnel SE (Paris:GET) and Oddo BHF as at 30 June 2017, the following stood to the credit of the liquidity account:
Graduated from the Ecole Nationale des Ponts et Chaussées, holder of a Master’s degree in Project Finance and with fifteen years of experience in Infrastructure Finance, Romain Fournier has joined Groupe Eurotunnel as Chief Financial Officer of ElecLink Limited.
The first stone of the future Freight Train Scanner, the first of its kind in France, has been laid by Jacques Gounon, Chairman and Chief Executive of Groupe Eurotunnel (Paris:GET) and Patrick Jeantet, Deputy Chairman of the Supervisory Board of SNCF and Chairman and Chief Executive of SNCF Réseau, at a ceremony held today at Calais-Frethun freight yard.
Groupe Eurotunnel (Paris:GET) announces that today, Friday 23 June 2017, after the expiry of the non-transfer period imposed by the Paris commercial court in 2012, its MyFerryLink business has sold its two ships Berlioz (now Côte des Flandres) and Rodin (now Côte des Dunes) to DFDS A/S on the terms agreed in the put option granted by DFDS A/S in June 2015.
LONDON, June 20 Stocks sensitive to the price of oil fell on Tuesday, putting pressure on European shares, with the pan-European benchmark ending lower after a strong start to the session.
In May 2017 Le Shuttle Freight transported 141,646 trucks, recording the best Truck Shuttle traffic for a month of May in its history, an increase of 3% compared to May 2016.
Announced on 9 May, the operation to refinance a part of the Group's floating rate debt was over-subscribed 2.5 times and the final pricing was concluded on Friday 19 May1
In April 2017, Le Shuttle Freight transported more than 130,000 trucks, a decrease of 6% compared to April 2016, due to an unfavourable calendar effect which this year saw the Easter weekend fall in the month of April. Since the start of the year, truck traffic has fallen slightly by 2%, heavily impacted by the exceptional weather conditions that hit southern Europe at the beginning of the year.
Moody's has assigned Baa2 ratings, outlook stable, to proposed new CLEF1 Notes and reaffirms Baa2 corporate rating to Eurotunnel, outlook stable.
As part of its ongoing strategy to optimise the structure of its debt and with a view to reducing the cost of its debt service, Groupe Eurotunnel (Paris:GET) today launched the refinancing of its floating rate debt1.
Jacques Gounon, Chairman and Chief Executive Officer of Groupe Eurotunnel SE (Paris:GET), accompanied by Xavier Bertrand, President of the Hauts-de-France Region, today inaugurated the first of three new, third generation Freight Shuttles.
Europorte France and its four unions, CGT, CFDT, SUD and CFTC, have signed a unanimous agreement on new working time arrangements in respect of the recent French Railway Reform.
Le Groupe Eurotunnel SE publie ses résultats annuels 2016. Jacques Gounon, Président-Directeur général du Groupe Eurotunnel commente les résultats et les perspectives.
7h - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
7h - Asif
BUSINESS TrovaGene is a clinical-stage, precision medicine oncology therapeutics company. The company's primary focus is to develop oncology therapeutics for improved cancer care and to optimize drug development by leveraging its proprietary Precision Cancer Monitoring® (“PCM”) technology in tumor genomics. The company's lead drug candidate, PCM-075, is a Polo-like Kinase 1 (“PLK1”) selective adenosine triphosphate (“ATP”) competitive inhibitor. PCM-075 has shown preclinical antitumor activity as a single agent and synergy in combination with more than ten different chemotherapeutics and targeted therapies, such as Zytiga® (abiraterone acetate), Beleodaq® (belinostat), Quizartinib (AC220), a development stage FLT3 inhibitor, and Velcade® (bortezomib) in Acute Myeloid Leukemia (“AML”), metastatic Castration-Resistant Prostate Cancer (“mCRPC”) and other hematologic and solid tumor cancers. On March 15, 2017, the company announced the licensing of PCM-075, a PLK1 inhibitor...
2018-05-19 - Asif
OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...